Kansai Medical University Hirakata Campus (IMAGE)

Kansai Medical University

Kansai Medical University Hirakata Campus

Caption

Kansai Medical University Hospital is actively participating in early Phase 1 international cancer drug development, conducting and contributing to several international clinical trials in an area of Japan and Asia where access to First-in-Human (FIH) Phase 1 clinical trials for new drugs has been limited. 

Credit

Toshio Shimizu from Kansai Medical University

Usage Restrictions

Cannot be used without permission.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.